Heart Valve Disease: Stenosis, Regurgitation, and Prolapse

Heart valve disease encompasses a range of structural abnormalities affecting the four valves of the heart — the aortic, mitral, tricuspid, and pulmonic — each of which can fail in distinct mechanical ways. The three most clinically significant failure patterns are stenosis (obstructed forward flow), regurgitation (backward leakage), and prolapse (abnormal leaflet displacement). Understanding these patterns matters because each carries a different hemodynamic burden, a different natural history, and a different set of intervention thresholds governed by guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA). This page covers the definition, mechanism, common clinical scenarios, and the decision boundaries that guide monitoring and treatment for each major valve disease type; the broader cardiology reference framework is available at the site index.

Definition and Scope

The ACC/AHA publish joint clinical practice guidelines for valvular heart disease — most recently updated in 2021 — that define disease severity in standardized terms applicable across all four valves (ACC/AHA 2021 Guideline for the Management of Patients With Valvular Heart Disease).

Stenosis refers to narrowing of a valve orifice that restricts forward blood flow. The aortic valve is the most commonly stenosed valve in adults, with calcific aortic stenosis representing the most prevalent form in patients over age 65, affecting approximately 2–5% of that population according to the ACC/AHA guidelines.

Regurgitation (also called insufficiency or incompetence) describes backward flow through a valve that fails to close completely. Mitral regurgitation is the most prevalent valvular lesion in the United States, with primary (degenerative) and secondary (functional) subtypes classified as distinct entities under the 2021 ACC/AHA framework.

Prolapse is a specific structural variant, most commonly affecting the mitral valve (mitral valve prolapse, or MVP), in which one or both leaflets bulge beyond the mitral annular plane into the left atrium during systole. MVP affects an estimated 2–3% of the general population, making it the most common structural heart abnormality, as noted by the National Heart, Lung, and Blood Institute (NHLBI: Mitral Valve Prolapse).

How It Works

Each failure mode imposes a distinct hemodynamic stress on the heart.

Stenosis: Pressure Overload

A stenotic valve forces the upstream chamber to generate substantially higher pressures to push blood through the narrowed orifice. In aortic stenosis, the left ventricle compensates through concentric hypertrophy — thickening of the ventricular wall. The ACC/AHA classify aortic stenosis severity by mean pressure gradient and aortic valve area (AVA):

  1. Mild: AVA greater than 1.5 cm²; mean gradient less than 20 mmHg
  2. Moderate: AVA 1.0–1.5 cm²; mean gradient 20–40 mmHg
  3. Severe: AVA less than 1.0 cm²; mean gradient greater than 40 mmHg
  4. Very severe: AVA less than 0.6 cm²; mean gradient greater than 60 mmHg

An echocardiogram is the primary imaging tool used to measure these gradients and valve areas non-invasively.

Regurgitation: Volume Overload

A leaking valve forces the upstream chamber to handle both its normal stroke volume and the regurgitant volume returning from the downstream vessel or chamber. This volume overload leads to eccentric hypertrophy — enlargement of the ventricular cavity. In chronic mitral regurgitation, the left ventricle can remain compensated for years before irreversible systolic dysfunction develops. Severity grading follows the ACC/AHA four-stage progression: A (at risk), B (progressive), C (asymptomatic severe), and D (symptomatic severe).

Prolapse: Structural Displacement with Variable Consequence

In MVP, the leaflet displacement itself does not necessarily cause hemodynamic impairment. The clinical significance depends on whether prolapse is accompanied by regurgitation. Isolated prolapse without significant regurgitation typically carries a benign prognosis. Prolapse with thickened, redundant leaflets (Barlow's disease pattern) carries a higher risk of progressive mitral regurgitation and, in a small subset, ventricular arrhythmias.

Common Scenarios

Calcific Aortic Stenosis in Older Adults
The most common presentation is an elderly patient with exertional dyspnea, angina, or syncope — the classic triad described in cardiovascular medicine. By the time severe symptomatic aortic stenosis develops, median survival without intervention is less than 2–3 years, according to the ACC/AHA 2021 guideline. Treatment pathways include surgical aortic valve replacement and transcatheter aortic valve replacement (TAVR), with choice guided by surgical risk scores and anatomic factors.

Primary Mitral Regurgitation from Degenerative Disease
Myxomatous degeneration, the underlying pathology in most cases of MVP and leaflet flail, is the leading cause of primary mitral regurgitation requiring surgery in developed countries. Patients may remain asymptomatic for a decade or more while the left ventricle progressively dilates. Surveillance imaging intervals are determined by severity stage under ACC/AHA guidance.

Rheumatic Mitral Stenosis
Rheumatic fever — caused by group A streptococcal infection — damages valve leaflets through an inflammatory process that leads to commissural fusion and progressive narrowing. Though rare in the United States, rheumatic mitral stenosis remains a leading cause of valve disease globally. The World Health Organization (WHO: Rheumatic Heart Disease) estimates rheumatic heart disease affects more than 40 million people worldwide.

Aortic Regurgitation from Aortic Root Disease
Aortic regurgitation can result from leaflet pathology (bicuspid aortic valve, endocarditis) or from aortic root dilation, which prevents leaflet coaptation. Bicuspid aortic valve — present in approximately 1–2% of the population — is the most common congenital cardiac anomaly and predisposes to both aortic stenosis and regurgitation over a lifetime.

Decision Boundaries

The ACC/AHA 2021 guideline uses a Class I–IIb recommendation structure to delineate when intervention is warranted versus when surveillance is appropriate. Key decision thresholds include:

Beyond these hard thresholds, risk stratification integrates the Society of Thoracic Surgeons (STS) Predicted Risk of Mortality (PROM) score for surgical candidates. Patients with STS PROM scores above 8% are generally classified as high surgical risk, making catheter-based approaches a primary consideration.

The regulatory and clinical oversight framework governing cardiology practice — including CMS coverage determinations for TAVR and other structural interventions — shapes which intervention pathways are available within institutional and payer-specific contexts.

Monitoring intervals for asymptomatic disease are also codified: severe asymptomatic aortic stenosis without intervention criteria warrants echocardiographic follow-up every 6–12 months; moderate aortic stenosis warrants annual to biennial imaging. These intervals are not discretionary — they reflect guideline-directed surveillance schedules designed to detect progression before irreversible ventricular remodeling occurs.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)